Ben Silverman, Insiderscore.com, provides perspective to some strong insider buying.» Read More
CNBC's David Faber reports Allergan has filed a lawsuit against Valeant Pharmaceuticals and Pershing Square's Bill Ackman alleging a violation of federal securities laws.
The SEC is expanding an insider trading investigation which may have started with congressional staffers. CNBC's Eamon Javers reports the details.
Icahn Enterprises chairman Carl Icahn discusses the insider trading investigation with CNBC's Scott Wapner.
U.S. Attorney SDNY Preet Bharara, says he doesn't think any institution is inherently corrupt, but corrupt cultures develop in some areas.
U.S. Attorney SDNY Preet Bharara, discusses the objective of the BNP Paribas criminal case.
U.S. Attorney SDNY Preet Bharara, provides insight to some of the most recent insider trading cases, and why some people are still committing this crime.
Cohen proved to be a stickler for the letter of the law when it came to paying the criminal penalty imposed on his former hedge fund. The NYT reports.
Former Federal prosecutor Mitch Epner, and CNBC's Scott Cohn discuss the acquittal of Rengan Rajaratnam on insider trading charges.
U.S. Attorney Preet Bharara has lost his first case since cracking down on insider trading. CNBC's Scott Cohn reports the jury has found Rengan Rajaratnam not guilty of conspiracy to commit insider trading.
CNBC's Scott Cohn reports the jury has found Rengan Rajaratnam not guilty of conspiracy.
The brother of an imprisoned ex-billionaire hedge fund founder has been acquitted of conspiracy.
CNBC's Scott Cohn reports insider trading charges have been dropped against Rengan Rajaratnam, according to wire stories. Rajaratnam still faces 1 count of conspiracy.
The probation department recommended 96 months of incarceration for ex-SAC Capital employee Mathew Martoma.
Officials are subpoenaing Dean Foods for information on activist investor Carl Icahn and golfer Phil Mickelson, the Wall Street Journal reports.
The authors of the recent study on insider trading that had Wall Street abuzz go a step further on exactly how rogue it is.
Prosecutors have issued subpoenas in an investigation into whether congressional staff tipped stock traders to a change in health-care policy. The WSJ reports.
One of the most breathtakingly incompetent ideas I've ever heard is the idea of legalizing all insider trading, says attorney Andrew Stoltmann.
A new study says insider trading may be involved in 25 percent of public company deals. That has some arguing that it should be legalized.
A New York Times article reveals a study of hundreds of deals involving public companies from 1996 through the end of 2012. 1 in 4 of those deals was surrounded by some kind of suspicious activity. CNBC contributor Carol Roth, and civil securities attorney Andrew Stoltmann, weigh in.
CNBC included Motif Investing in its "Disruptor 50" list this year. Its co-founder & CEO Hardeep Walia, says shale, China internet and transportation are current motifs his company is eyeing.